SPONSOR
Nanjing Leads Biolabs Co.,Ltd
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2, Phase 1, Phase 2
Nanjing Leads Biolabs Co.,Ltd is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Systemic Lupus Erythematosus, Advanced Solid Tumour, Ovarian Cancer.
The trial portfolio spans Phase 1, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nanjing Leads Biolabs Co.,Ltd
How many clinical trials has Nanjing Leads Biolabs Co.,Ltd sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Nanjing Leads Biolabs Co.,Ltd, of which 4 are actively recruiting participants. These trials cover conditions including Systemic Lupus Erythematosus, Advanced Solid Tumour, Ovarian Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nanjing Leads Biolabs Co.,Ltd research focus on?
Nanjing Leads Biolabs Co.,Ltd clinical trials span Systemic Lupus Erythematosus, Advanced Solid Tumour, Ovarian Cancer. The research pipeline includes Phase 1, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nanjing Leads Biolabs Co.,Ltd clinical trial?
To participate in a Nanjing Leads Biolabs Co.,Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanjing Leads Biolabs Co.,Ltd trials with current recruitment status updated daily.
Clinical Trials by Nanjing Leads Biolabs Co.,Ltd
NCT07323173 Phase 1
Recruiting
A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
NCT06783647 Phase 2
Recruiting
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
Advanced Solid Tumour
NCT07111546 Phase 2
Recruiting
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Advanced Solid Tumour
NCT07042802 Phase 1, Phase 2
Recruiting
A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer
Ovarian Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology